BREAKING: US FDA Sets PDUFA for Roflumilast Cream 0.05% in Infants With AD The Dermatology Digest Source link
CHMP Issues Positive Opinion for Ruxolitinib Cream for Adults With Moderate AD The Dermatology Digest Source link
US FDA Approves Less Frequent Lebrikizumab Dosing in AD The Dermatology Digest Source link
Journal Digest: September 3 Dermatology Times Source link